Document Detail

Lack of TGFβ Production by Hepatitis C Virus-Specific T Cells during HCV Acute Phase is Associated with HCV Clearance in HIV co-infection.
MedLine Citation:
PMID:  22326469     Owner:  NLM     Status:  Publisher    
BACKGROUND & AIMS: Immunity and genetic factors govern recovery from acute hepatitis C virus (HCV) infection. No predictive factors have yet been identified in patients coinfected with the human immunodeficiency virus (HIV). We investigated whether early T cell responses to HCV producing transforming-growth-factor beta (TGFβ) predict the outcome of acute HCV coinfection, independently of the IL-28B gene polymorphism. METHODS: Intracellular-cytokine-staining assays against HCV-core, E1, NS2 and NS4 overlapping peptides analyzed peripheral HCV-specific TGFβ-producing T cells. Patients were genotyped for IL-28B polymorphisms. Healthy donors' samples were tested as controls. Twenty-four acute hepatitis C-HIV+ patients were followed-up for 15 months defining two groups: A) Recovered (n=16: 5 spontaneous recoveries, 11 sustained virologic response after treatment), B) Chronic HCV (n=8: 4 spontaneous chronic course, 4 therapeutic failures). RESULTS: During the acute pretreatment phase, core/NS2-specific TGFβ-producing CD4+ and/or CD8+ T cells were detected in 8/24 (33%) patients. Lack of anti-HCV TGFβ+ cells was characteristic of healthy donors and Group A, except in 2 cases, with frequencies significantly lower than in Group B (p=0.04 and 0.01), and was associated with recovery in 14/16 cases. Presence of anti-HCV TGFβ+ cells was associated with persistent viremia in 6/8 cases (p=0.005). This profile remained stable over time. Such TGFβ production was independent of the rs129679860 SNP (p= 1.0) which was not associated with recovery (p=1.0). CONCLUSIONS: During acute hepatitis C, pre-therapeutic HCV-specific TGFβ-producing T cells are a new marker independent of the IL-28B gene polymorphism, predicting the lack of spontaneous or therapeutic HCV clearance.
Sawsan Harfouch; Marguerite Guiguet; Marc-Antoine Valantin; Assia Samri; Zineb Ouazene; Laurence Slama; Stéphanie Dominguez; Anne Simon; Ioannis Theodorou; Vincent Thibault; Brigitte Autran
Related Documents :
22670599 - Patterns of condom use among students at historically black colleges and universities: ...
22533309 - Trends in attitudes toward people living with hiv, homophobia, and hiv transmission kno...
22292479 - Combined effects of aging and hiv infection on semantic verbal fluency: a view of the c...
22310829 - Genital mycoplasma & chlamydia trachomatis infections in treatment naïve hiv-1 infecte...
22832709 - Coreceptor usage in different reservoirs.
22685549 - Prospective monitoring reveals dynamic levels of t cell immunity to mycobacterium tuber...
8652699 - Determinants of hiv risk among men who have homosexual sex and inject drugs.
11526689 - Is seborrhoeic dermatitis a clinical marker of hiv disease?
21521929 - Prevalence of and risk factors for lipodystrophy among hiv-infected patients receiving ...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-2-9
Journal Detail:
Title:  Journal of hepatology     Volume:  -     ISSN:  0168-8278     ISO Abbreviation:  -     Publication Date:  2012 Feb 
Date Detail:
Created Date:  2012-2-13     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8503886     Medline TA:  J Hepatol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012. Published by Elsevier B.V.
INSERM, UMRS-945, Hôpital Pitié-Salpêtrière, Laboratoire d'Immunologie Cellulaire et Tissulaire F-75013, Paris, France; UPMC Université Paris 06, UMRS-945, Hôpital Pitié-Salpêtrière, Laboratoire d'Immunologie Cellulaire et Tissulaire F-75013, Paris, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Bacterial translocation and changes in the intestinal microbiome in mouse models of liver disease.
Next Document:  Antiviral activity of TMC435 monotherapy in patients infected with HCV genotypes 2-6: TMC435-C202, a...